首页> 外文学位 >The Use of Fragment-Based Lead Discovery Towards the Design and Development of Metalloenzyme Inhibitors.
【24h】

The Use of Fragment-Based Lead Discovery Towards the Design and Development of Metalloenzyme Inhibitors.

机译:使用基于片段的线索发现进行金属酶抑制剂的设计和开发。

获取原文
获取原文并翻译 | 示例

摘要

The use of fragment-based lead discovery (FBLD) for the design and development of metalloenzyme inhibitors is examined. This thesis will first discuss the method of FBLD and compare it to more traditional drug discovery approaches, such as high-throughput screening (HTS). After establishing the concepts behind FBLD, the applications of utilizing a FBLD approach towards the development of inhibitors for select metalloenzymes is discussed.;A study into the use of a chelator fragment library (CFL) to identify new metal-binding groups (MBG) for metalloprotein inhibitors is discussed. The results of screening this library against a number of metalloenzymes identified important trends between classes of chelators in addition to the identification of numerous metalloenzyme specific MBGs. Furthermore this study provides evidence that the CFL can be used as useful tool in metalloenzyme inhibitor design.;A second probes the types of key interactions a metal-binding inhibitor must posses to effectively inhibit the dinuclear metalloenzyme HIV-1 integrase (HIV-1 IN). A small library of compounds varying only in composition of their MBG was prepared. The activity of this series of compounds was also compared to a similar HIV-1 IN FDA-approved drug. Screening this library of compounds led to the identification of a potentially unique and more potent scaffold (hydroxypyrone-based compounds) for HIV-1 IN inhibitors. Additionally, a small sublibrary of compounds was developed to explore the effects of manipulating the pKa of the chelator. The results of the systematic examination of the role the MBG contributes to HIV-1 IN inhibition are discussed.;Lastly, the discovery of two novel metal-binding scaffolds for the development Pseudomonas aeruginosa elastase (LasB) inhibitors is discussed. Further use of the above mentioned CFL, helped to identify the first nonpeptidic small molecule inhibitors of LasB. These compounds, in addition to displaying selective antagonism for LasB against a panel of similar metalloenzymes, also confirmed the role the enzyme plays in the swarming behavior of this organism.
机译:检查了基于片段的铅发现(FBLD)在金属酶抑制剂设计和开发中的用途。本文将首先讨论FBLD的方法,并将其与更传统的药物发现方法进行比较,例如高通量筛选(HTS)。在确立了FBLD的概念之后,讨论了利用FBLD方法开发用于选择金属酶的抑制剂的应用。研究了使用螯合剂片段库(CFL)识别新的金属结合基团(MBG)的研究。讨论了金属蛋白抑制剂。针对多种金属酶筛选该文库的结果,除了鉴定出多种金属酶特异性MBG之外,还发现了螯合剂类别之间的重要趋势。此外,这项研究提供了证据,证明CFL可以用作金属酶抑制剂设计中的有用工具。;第二个探查金属结合抑制剂为有效抑制双核金属酶HIV-1整合酶(HIV-1 IN )。制备了一个仅由MBG组成变化的化合物的小型文库。还将该系列化合物的活性与类似的HIV-1 IN FDA批准的药物进行了比较。筛选该化合物库可鉴定出潜在的独特且更有效的HIV-1 IN抑制剂支架(基于羟基吡喃酮的化合物)。另外,开发了化合物的小库,以探索操纵螯合剂pKa的作用。讨论了MBG对HIV-1 IN抑制作用的系统检查结果。最后,讨论了两种新型铜绿假单胞菌弹性蛋白酶(LasB)抑制剂的金属结合支架的发现。上述CFL的进一步使用有助于鉴定LasB的第一个非肽类小分子抑制剂。这些化合物除了对LasB表现出对一组类似金属酶的选择性拮抗作用外,还证实了该酶在该生物群中的作用。

著录项

  • 作者

    Sardo, Jessica L.;

  • 作者单位

    University of California, San Diego.;

  • 授予单位 University of California, San Diego.;
  • 学科 Chemistry Organic.;Chemistry Biochemistry.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 233 p.
  • 总页数 233
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号